Orexigen Therapeutics

FDA approves weight-management drug Contrave

Friday, September 12, 2014

The FDA has approved Contrave (naltrexone hydrochloride and bupropion hydrochloride extended-release tablets) as treatment option for chronic weight management in addition to a reduced-calorie diet and physical activity.

[Read More]